Subcutaneous herceptin - PowerPoint PPT Presentation


Overview of Superficial Fungal Infections of the Skin

Superficial fungal infections of the skin are categorized into superficial, cutaneous, and subcutaneous types. Superficial mycoses affect the stratum corneum and include conditions like tinea versicolor, tinea nigra, and piedra. Tinea versicolor is a chronic infection caused by Malassezia furfur, wh

3 views • 31 slides


Defibrillator Market

'Defibrillator Market by Product (Implantable (ICD) [Transvenous {Dual Chamber, Single-chamber, CRT-D}, Subcutaneous], External (ECD) [Manual, Automated, Wearable]), End User (Hospital, Emergency Care, Home Care), Age Group \u2013 Global Forecast to 2031.

2 views • 4 slides



Understanding Fungi Diversity and Infections in Microbiology

Explore the world of fungi and fungal infections in this foundation block of microbiology. Learn about medically important yeasts, mold fungi, major fungal diseases, antifungal agents, and infection acquisition methods. Dive into hypersensitivity reactions, mycotoxicoses, and various types of fungal

1 views • 19 slides


Understanding Lipomas: Clinical Features and Management Guidelines

Lipomas are common benign tumors that often present as small, painless, subcutaneous masses. This summary provides insights into the clinical features of lipomas, including their typical characteristics and management recommendations. It emphasizes the importance of reassurance, observation, and app

3 views • 10 slides


Understanding Stephanurus Dentatus: Kidney Worm of Pigs

Stephanurus dentatus is a parasitic worm that infects pigs, with an intricate life cycle involving earthworms as transport hosts. Transmission occurs through ingestion of larvae or infected earthworms, leading to various pathological effects, including subcutaneous nodules, cirrhosis, and organ dama

0 views • 13 slides


Understanding Intravenous Infusions and Injections in Healthcare

Intravenous infusions and injections play crucial roles in healthcare by delivering drugs and fluids directly into the body. Injections can be administered in various ways, including intravenous, intramuscular, and subcutaneous routes. Intravenous infusions provide fluids, electrolytes, and medicati

4 views • 20 slides


Subcutaneous Secukinumab in Psoriatic Arthritis: FUTURE 5 Study Results

The FUTURE 5 study examined the efficacy of subcutaneous secukinumab in inhibiting radiographic progression and improving clinical outcomes in psoriatic arthritis. Results showed significant improvement in ACR20, inhibition of structural damage progression, and resolution of enthesitis and dactyliti

0 views • 30 slides


Understanding Urticaria and Angioedema: Symptoms, Causes, and Treatment

Urticaria, commonly known as hives, and angioedema are skin conditions characterized by red, raised welts and swelling. Urticaria typically lasts less than 24 hours and can occur anywhere on the body, while angioedema involves episodic swelling of subcutaneous or submucosal tissues. Causes include i

0 views • 23 slides


Understanding Zoonotic Diseases and Mycoses

Zoonotic diseases, caused by fungi, have the potential to affect both animals and humans and are often transmitted through various environmental factors. These diseases can lead to a range of conditions affecting different organs and structures of the body. Mycoses, such as superficial and systemic

0 views • 19 slides


Comprehensive Medical History of Mrs. B: Breast Cancer Journey

Mrs. B, a 49-year-old woman, was diagnosed with invasive ductal carcinoma in her left breast in December 2000. She underwent various treatments including surgery, chemotherapy, radiotherapy, and targeted therapies like Herceptin. Despite complications and ongoing pain, she has shown resilience throu

1 views • 32 slides


Safety and Antiviral Activity of GS-6207: A First-in-Class HIV Capsid Inhibitor

GS-6207 is a novel long-acting HIV capsid inhibitor with promising antiviral activity and safety profile in people living with HIV. The study evaluates the efficacy of a single subcutaneous dose of GS-6207 in reducing plasma HIV-1 RNA levels over 10 days. Results show potential benefits for heavily

0 views • 13 slides


Audit on Subcutaneous Herceptin Administration Reactions

An audit was conducted to monitor reactions to subcutaneous Herceptin administration, with a total of 618 doses given to 110 patients. Only 2.7% of patients experienced reactions. Recommendations on observation requirements post-administration were made based on the findings.

0 views • 12 slides